SCHEMBL6708976

SCHEMBL6708976

O=C(Nc1ccc(Br)cc1-c1noc(=O)[nH]1)c1noc2cc(Cl)ccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.51
HIF1A Q16665 6/20 0.43
GPR35 Q9HC97 3/20 0.36
F11 P03951 2/20 0.36
ACLY P53396 1/20 0.34
HPGD P15428 2/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GRM5 P41594 1/20 0.34
SLC10A6 Q3KNW5 2/20 0.34
DNMT3A Q9Y6K1 1/20 0.34
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6709033 0.93 HIF1A (0.49) GRIK1HIF1AF11KMT2AGRM5
SCHEMBL6708659 0.90 GRIK1 (0.51) GRIK1HIF1AGPR35F11HPGD
SCHEMBL6708927 0.90 GRIK1 (0.41) GRIK1HIF1AHPGDKMT2AMEN1
SCHEMBL6710484 0.89 HIF1A (0.46) GRIK1HIF1AF11KMT2AMEN1
SCHEMBL6707696 0.89 GRIK1 (0.40) GRIK1HIF1AHPGDKMT2AMEN1
SCHEMBL6709940 0.87 HIF1A (0.51) GRIK1HIF1A
SCHEMBL6709887 0.87 GRIK1 (0.43) GRIK1HIF1AHPGDKMT2AMEN1
SCHEMBL6709984 0.86 HIF1A (0.45) GRIK1HIF1AF11RAB9AGRM5
SCHEMBL6713307 0.86 HIF1A (0.41) GRIK1HIF1AF11KMT2AMEN1
SCHEMBL6707793 0.86 HIF1A (0.45) GRIK1HIF1AGPR35HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885HIF1A 296/4885GPR35 2928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.